In Vitro Diagnostics



• Multiplex N1 + N3 detection of SARS CoV-2 plus human Endogenous RNA • Highly Sensitive and Quantitative
• Progressive monitor disease by Absolute and Normalized Viral Load
• Clinically Validated on Nasopharyngeal and Oro-Salivary Swabs

• Option of Rapid Thermal Extraction



Funded by an Italian Pharmaceutical company, Hiantis is developing a new fixed injectable drug combination for the prevention and treatment of osteoporosis.

For more information write to:

Medical Devices


Hiantis has undertaken a preliminary commercial phase of dermocosmetics and a medical device with astringent and antimicrobial properties for topical use

For more information write to:

Discover The Future

Contact Us